i-SENS, Inc. (KOSDAQ:099190)

South Korea flag South Korea · Delayed Price · Currency is KRW
21,200
-600 (-2.75%)
Apr 28, 2026, 3:30 PM KST
34.35%
Market Cap 608.45B
Revenue (ttm) 315.44B
Net Income (ttm) -5.15B
Shares Out 28.70M
EPS (ttm) -187.00
PE Ratio n/a
Forward PE 137.89
Dividend 100.00 (0.46%)
Ex-Dividend Date Dec 29, 2025
Volume 180,703
Average Volume 116,210
Open 22,450
Previous Close 21,800
Day's Range 21,000 - 22,450
52-Week Range 14,600 - 27,600
Beta 1.06
RSI 54.48
Earnings Date May 15, 2026

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headq... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2000
Employees 887
Stock Exchange KOSDAQ
Ticker Symbol 099190
Full Company Profile

Financial Performance

In 2025, i-SENS's revenue was 315.44 billion, an increase of 8.35% compared to the previous year's 291.14 billion. Losses were -5.15 billion, 187.0% more than in 2024.

Financial Statements

News

There is no news available yet.